Sports Medicine

, Volume 30, Issue 3, pp 171–192 | Cite as

Exercise Following Heart Transplantation

Review Article


During the past 2 decades, heart transplantation has evolved from an experimental procedure to an accepted life-extending therapy for patients with end-stage heart failure. However, with dramatic improvements in organ preservation, surgery and immunosuppressive drug management, short term survival is no longer the pivotal issue for most heart transplant recipients (HTR). Rather, a return to functional lifestyle with good quality of life is now the desired procedural outcome. To achieve this outcome, aggressive exercise rehabilitation is essential.

HTR present unique exercise challenges. Preoperatively, most of these patients had chronic debilitating cardiac illness. Many HTR have had prolonged pretransplantation hospitalisation for inotropic support or a ventricular assist device. Decrements in peak oxygen consumption (V̇O2peak) and related cardiovascular parameters regress approximately 26% within the first 1 to 3 weeks of sustained bed rest. Consequently, extremely poor aerobic capacity and cardiac cachexia are not unusual occurrences in HTR who have required mechanical support or been confined to bed rest. Moreover, HTR must also contend with de novo exercise challenges conferred by chronic cardiac denervation and the multiple sequelae resulting from immunosuppression therapy.

There is ample evidence that both endurance and resistance training are well tolerated in HTR. Moreover, there is growing clinical consensus that specific endurance and resistance training regimens in HTR can be efficacious adjunctive therapies in the prevention of immunosuppression-induced adverse effects and the reversal of pathophysiological consequences associated with cardiac denervation and antecedent heart failure. For example, some HTR who remain compliant during strenuous long term endurance training programmes achieve peak heart rate and V̇O2peak values late after transplantation that approach age-matched norms (up to approximately 95% of predicted). These benefits are not seen in HTR who do not participate in structured endurance exercise training. Rather, peak heart rate and V̇O2peak values in untrained HTR remain approximately 60 to 70% of predicted indefinitely. However, the mechanisms responsible for improved peak heart rate, V̇O2peak and total exercise time are not completely understood and require further investigation. Recent studies have also demonstrated that resistance exercise training may be an effective countermeasure for corticosteroid-induced osteoporosis and skeletal muscle myopathy. HTR who participate in specific resistance training programmes successfully restore bone mineral density (BMD) in both the axial and appendicular skeleton to pretransplantation levels, increase lean mass to levels greater than pretransplantation, and reduce body fat. In contrast, HTR who do not participate in resistance training lose approximately 15% BMD from the lumbar spine early in the postoperative period and experience further gradual reductions in BMD and muscle mass late after transplantation.


  1. 1.
    Braith RW, Mills RM. Exercise training in patients with congestive heart failure: how to achieve benefits safely. Postgrad Med 1996; 96: 119–30Google Scholar
  2. 2.
    Kaye MP, Randall WC, Hageman GR, et al. Chronology and mode of reinnervation of the surgically denervated canine heart: functional and chemical correlates. Am J Physiol 1977; 233: H431–7PubMedGoogle Scholar
  3. 3.
    Willman VL, Cooper T, Hanlon C. Return of neural responses after autotransplantation of the heart. Am J Physiol 1964; 207: 187–9PubMedGoogle Scholar
  4. 4.
    Kontos HA, Thames MD, Lower RR. Responses to electrical and reflex autonomic stimulation in dogs with cardiac transplantation before and after reinnervation. J Thorac Cardiovasc Surg 1970; 59: 382–92PubMedGoogle Scholar
  5. 5.
    Rowan RA, Billingham ME. Myocardial innervation in longterm heart transplant survivors: a quantitative ultrastructural survey. J Heart Transplant 1988; 7: 448–52PubMedGoogle Scholar
  6. 6.
    Regitz V, Bossaller C, Strasser R, et al. Myocardial catecholamine content after heart transplantation. Circulation 1990; 82: 620–3PubMedGoogle Scholar
  7. 7.
    Wilson RF, Christensen BV, Olivari MT, et al. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation 1991; 83: 1210–20PubMedGoogle Scholar
  8. 8.
    Wilson RF, Laxson DD, Christensen BV, et al. Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation. Circulation 1993; 88: 165–71PubMedGoogle Scholar
  9. 9.
    Burke MN, McGinn AL, Homans DC, et al. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation 1995; 91: 72–8PubMedGoogle Scholar
  10. 10.
    Kaye DM, Lambert GW, Lefkovits J, et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994; 23: 570–8PubMedGoogle Scholar
  11. 11.
    Lord SW, Brady S, Holt ND, et al. Exercise response after cardiac transplantation: correlation with sympathetic reinnervation. Heart 1996; 75: 40–3PubMedGoogle Scholar
  12. 12.
    Schwaiger M, Hutchins GD, Kaiff V, et al. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991; 87: 1681–90PubMedGoogle Scholar
  13. 13.
    Bernardi L, Bianchini B, Spadacini G, et al. Demonstrable cardiac reinnervation after human heart transplantation by carotid baroreflex modulation of RR interval. Circulation 1995; 92: 2895–903PubMedGoogle Scholar
  14. 14.
    Meyer M, Marconi C, Ferretti G, et al. Heart rate variability in the human transplanted heart: nonlinear dynamics and QT vs RR-QT alterations during exercise suggest a return of neurocardiac regulation in long-term recovery. Integr Physiol Behav Sci 1996; 31: 289–305PubMedGoogle Scholar
  15. 15.
    Lord SW, Clayton RH, Mitchell L, et al. Sympathetic reinnervation and heart rate variability after cardiac transplantation. Heart 1997; 77: 532–8PubMedGoogle Scholar
  16. 16.
    DeMarco T, Dae M, Yuen-Green MS, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995; 25: 927–31Google Scholar
  17. 17.
    Kavanagh T, Yacoub M, Mertens D, et al. Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation 1988; 77: 162–71PubMedGoogle Scholar
  18. 18.
    Keteyian S, Shepard R, Ehrman J, et al. Cardiovascular responses of heart transplant patients to exercise training. J Appl Physiol 1991; 70: 2627–31PubMedGoogle Scholar
  19. 19.
    Rudas L, Pflughelder PW, Menkes AH, et al. Evolution of heart rate responsiveness after orthotopic cardiac transplantation. Am J Cardiol 1991; 68: 232–6PubMedGoogle Scholar
  20. 20.
    Richard R, Verdier JC, Duvallet A, et al. Chronotropic competence in endurance trained heart transplant recipients: heart rate is not a limiting factor for exercise capacity. J Am Coll Cardiol 1999; 33: 192–7PubMedGoogle Scholar
  21. 21.
    Kobashigawa J, Leaf DA, Lee N, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 1999; 340: 272–7PubMedGoogle Scholar
  22. 22.
    Mercier J, Ville N, Wintrebert P, et al. Influence of post-surgery time after cardiac transplantation on exercise responses. Med Sci Sports Exerc 1996; 28: 171–5PubMedGoogle Scholar
  23. 23.
    Givertz MM, Hartley LH, Colucci WS. Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. Circulation 1997; 96: 232–7PubMedGoogle Scholar
  24. 24.
    Mandak J, Aaronson K, Mancini D. Serial assessment of exercise capacity after heart transplantation. J Heart Lung Transplant 1995; 14: 468–78PubMedGoogle Scholar
  25. 25.
    Ueberfuhr P, Ziegler S, Schwaiblmair M, et al. Functional significance of the sympathetic re-innervated orthotopically transplanted human heart [abstract]. Circulation 1996; 94 Suppl. I: I–291AGoogle Scholar
  26. 26.
    Quigg R, Rocco MB, Gauthier DF, et al. Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation. J Am Coll Cardiol 1989; 14: 338–44PubMedGoogle Scholar
  27. 27.
    Braith RW, Wood CE, Limacher MC, et al. Abnormal neuroendocrine responses during exercise in heart transplant recipients. Circulation 1992; 86: 1453–63PubMedGoogle Scholar
  28. 28.
    Braith RW, Welsch MA, Mills RM, et al. Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients. Med Sci Sports Exerc 1998; 30: 483–9PubMedGoogle Scholar
  29. 29.
    Kao AC, Van Tright P, Shaeffer-McCall GS, et al. Central and peripheral limitations to upright exercise in untrained cardiac transplant recipients. Circulation 1994; 89: 2605–15PubMedGoogle Scholar
  30. 30.
    Kao AC, Van Trigt P, Shaeffer-Mccall GS, et al. Allograft diastolic dysfunction and chronotropic incompetence limit cardiac output response to exercise two to six years after heart transplantation. J Heart Lung Transplant 1995; 14: 11–22PubMedGoogle Scholar
  31. 31.
    Pflugfelder PW, Purves PD, McKenzie FN, et al. Cardiac dynamics during supine exercise in cyclosporine treated orthotopic heart transplant recipients: assessment by radionuclide angiography. J Am Coll Cardiol 1987; 10: 336–41PubMedGoogle Scholar
  32. 32.
    Martin TW, Gaucher J, Pupa LE, et al. Response to upright exercise after cardiac transplantation. Clin Cardiol 1994; 17: 292–300PubMedGoogle Scholar
  33. 33.
    Pope SE, Stinson EB, Daughter GT, et al. Exercise response of the denervated heart in long-term cardiac transplant recipients. Am J Cardiol 1978; 46: 213–8Google Scholar
  34. 34.
    Kemp DL, Jennison SH, Stelken AM, et al. Association of resting heart rate and chronotropic response. Am J Cardiol 1995; 75: 751–2PubMedGoogle Scholar
  35. 35.
    Braith RW, Clapp L, Mills RM, et al. Rate responsive cardiac pacing increases exercise capacity in heart transplant recipients [abstract]. Med Sci Sports Exerc 1999; 31 Suppl.: S339Google Scholar
  36. 36.
    Levine MA, Leenen FH. Role of β1 receptors and vagal tone in cardiac inotropic responses and chronotropic responses to β2 agonist in humans. Circulation 1989; 79: 107–15PubMedGoogle Scholar
  37. 37.
    Bexton RS, Milne JR, Cory-Pearce R, et al. Effect of beta blockade on exercise response after cardiac transplantation. Br Heart J 1983; 49: 584–8PubMedGoogle Scholar
  38. 38.
    Yusuf S, Theodoropoulos S, Dhalla N, et al. Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantation. Am J Cardiol 1989; 64: 636–41PubMedGoogle Scholar
  39. 39.
    Leenen FH, Davies RA, Fourney A. Role of cardiac β2-receptors in cardiac responses to exercise in cardiac transplant patients. Circulation 1995; 91: 685–90PubMedGoogle Scholar
  40. 40.
    Braith RW, Plunkett MB, Mills RM. Cardiac output responses during exercise in volume expanded heart transplant recipients. Am J Cardiol 1998; 81: 1152–6PubMedGoogle Scholar
  41. 41.
    Keteyian S, Marks CRC, Levine AB, et al. Cardiovascular responses of cardiac transplant patients to arm and leg exercise. Eur J Appl Physiol 1994; 68: 441–4Google Scholar
  42. 42.
    Greenberg ML, Uretsky BF, Reddy PS, et al. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation 1985; 71: 487–94PubMedGoogle Scholar
  43. 43.
    Burger W, Hartmann A, Herholz C, et al. Right ventricular volumes and hemodynamics after successful orthotopic heart transplantation: a comparison to coronary artery disease using thermodilution. Int J Cardiol 1992; 37: 155–63PubMedGoogle Scholar
  44. 44.
    Younis LT, Melin JA, Schoevaerdts JC, et al. Left ventricular systolic function and diastolic filling at rest and during upright exercise after orthotopic heart transplantation: comparison with young and aged normal subjects. J Heart Transplant 1990; 9: 683–92PubMedGoogle Scholar
  45. 45.
    Hospenpud JD, Morton MJ, Wilson RA, et al. Abnormal exercise hemodynamics in cardiac allograft recipients 1 year after cardiac transplantation: relation to preload reserves. Circulation 1989; 80: 525–32Google Scholar
  46. 46.
    Hosenpud JD, Stibolt TA, Atwal K, et al. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990; 88: 493–6PubMedGoogle Scholar
  47. 47.
    Reid CJ, Yacoub MH. Determinants of left ventricular function one year after cardiac transplantation. Br Heart J 1988; 59: 397–402PubMedGoogle Scholar
  48. 48.
    Teo KK, Yusuf S, Wittes J, et al. Preserved left ventricular function during supine exercise in patients after cardiac transplantation. Eur Heart J 1992; 13: 321–9PubMedGoogle Scholar
  49. 49.
    Hartmann A, Maul FD, Huth A, et al. Serial evaluation of left ventricular function by radionuclide ventriculography at rest and during exercise after orthotopic heart transplantation. Eur J Nucl Med 1993; 20: 146–50PubMedGoogle Scholar
  50. 50.
    Rudas L, Pflugheider PW, McKenzie FN, et al. Normalization of upright exercise hemodynamics and improved exercise capacity one year after orthotopic cardiac transplantation. Am J Cardiol 1992; 69: 1336–9PubMedGoogle Scholar
  51. 51.
    Borow KM, Neumann A, Arensman FW, et al. Left ventricular contractility and contractile reserve in humans after cardiac transplantation. Circulation 1985; 71: 866–72PubMedGoogle Scholar
  52. 52.
    Geny B, Saini J, Mettauer B, et al. Effect of short-term endurance training on exercise capacity, hemodynamics and atrial natriuretic peptide secretion in heart transplant recipients. Eur J Appl Physiol 1996; 73: 259–66Google Scholar
  53. 53.
    Rudas L, Pflugfelder P, Kostuk W. Comparison of hemodynamic responses during dynamic exercise in the upright and supine postures after orthotopic cardiac transplantation. J Am Coll Cardiol 1990; 16: 1367–73PubMedGoogle Scholar
  54. 54.
    Braith RW, Mills RM, Wilcox CS, et al. Fluid homeostasis after heart transplantation: the role of cardiac denervation. J Heart Lung Transplant 1996; 15: 872–80PubMedGoogle Scholar
  55. 55.
    Bellet M, Cabrol C, Sassano P, et al. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the reninangiotensin-aldosterone system. Am xJ Cardiol 1985; 56: 927–31Google Scholar
  56. 56.
    Pflugfelder PW, McKenzie FN, Kostuk WJ. Hemodynamic profiles at rest and during supine exercise after orthotopic cardiac transplantation. Am J Cardiol 1988; 61: 1328–33PubMedGoogle Scholar
  57. 57.
    Pflugfelder PW, Purves PD, Menkis AH, et al. Rest and exercise left ventricular ejection and filling characteristics following orthotopic cardiac transplantation. Can J Cardiol 1989; 5: 161–7PubMedGoogle Scholar
  58. 58.
    Braith RW, Limacher MC, Mills RM, et al. Exercise-induced hypoxemia in heart transplant recipients. J Am Coll Cardiol 1993; 22: 768–76PubMedGoogle Scholar
  59. 59.
    Paulus WJ, Bronzwaer JGF, Felice H, et al. Deficient acceleration of left ventricle relaxation during exercise after heart transplantation. Circulation 1992; 86: 1175–85PubMedGoogle Scholar
  60. 60.
    Stratton JR, Levy WC, Schwartz RS, et al. Beta-adrenergic effects on left ventricular filling: influence of aging and exercise training. J Appl Physiol 1994; 77: 2522–9PubMedGoogle Scholar
  61. 61.
    Casan P, Sanchis J, Cladellas M, et al. Diffusing lung capacity and cyclosporine in patients with heart transplants. J Heart Transplant 1987; 6: 54–6PubMedGoogle Scholar
  62. 62.
    Bussieres LM, Pflugfelder PW, Ahmad D, et al. Early changes in static and dynamic pulmonary function after cardiac transplantation [abstract]. J Heart Lung Transplant 1992; 11: 226Google Scholar
  63. 63.
    Ohar J, Osterloh J, Ahmed N, et al. Diffusing capacity decreases after heart transplantation. Chest 1993; 103: 857–61PubMedGoogle Scholar
  64. 64.
    Jahnke AW, Leyh R, Guha M, et al. Time course of lung function and exercise performance after heart transplantation. J Heart Lung Transplant 1994; 13: 412–7PubMedGoogle Scholar
  65. 65.
    Ville N, Mercier J, Varray A, et al. Exercise tolerance in heart transplant patients with altered pulmonary diffusion capacity. Med Sci Sports Exerc 1998; 30: 339–44PubMedGoogle Scholar
  66. 66.
    Egan JJ, Kalra S, Yonan N, et al. Pulmonary diffusion abnormalities in heart transplant recipients. Chest 1993; 104: 1085–9PubMedGoogle Scholar
  67. 67.
    Squires RW, Hoffman CJ, James GA, et al. Arterial oxygen saturation during graded exercise testing after cardiac transplantation [abstract]. J Cardiopulm Rehabil 1998; 18: 348Google Scholar
  68. 68.
    Mancini DM, Henson D, LaManca J, et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992; 86: 909–18PubMedGoogle Scholar
  69. 69.
    Drexler H, Reide U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1751–9PubMedGoogle Scholar
  70. 70.
    Sullivan J, Green H, Cobb F. Skeletal muscle biochemistry and histology in ambulatory patients with long term heart failure. Circulation 1990; 81: 518–27PubMedGoogle Scholar
  71. 71.
    Sullivan J, Green H, Cobb F. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Circulation 1991; 84: 1597–607PubMedGoogle Scholar
  72. 72.
    Schaufelberger M, Erikson B, Held P, et al. Skeletal muscle metabolism during exercise in patients with chronic heart failure. Heart 1996; 76: 29–34PubMedGoogle Scholar
  73. 73.
    Mettauer B, Lampert E, Petitjean P, et al. Persistent exercise intolerance following cardiac transplantation despite normal oxygen transport. Int J Sports Med 1996; 17: 277–86PubMedGoogle Scholar
  74. 74.
    Bussieres LM, Pflughelder PW, Menkis AH, et al. Basis for aerobic impairment in patients after heart transplantation. J Heart Lung Transplant 1995; 14: 1073–80PubMedGoogle Scholar
  75. 75.
    Kinney T. Glucocorticoid-induced muscle atrophy. J Cardiopulm Rehabil 1997; 17: 76–84Google Scholar
  76. 76.
    Khaleeli A, Edwards R, Gohil K, et al. Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol 1983; 18: 155–66Google Scholar
  77. 77.
    Hickson RC, Marone JR. Exercise and inhibition of glucocorticoid-induced muscle atrophy. Exerc Sport Sci Rev 1993; 21: 135–67PubMedGoogle Scholar
  78. 78.
    Biring M, Fournier M, Ross D, et al. Cellular adaptations of skeletal muscle to cyclosporine. J Appl Physiol 1998; 84: 1967–75PubMedGoogle Scholar
  79. 79.
    Bussieres LM, Pflugfelder PW, Taylor AW, et al. Changes in skeletal muscle morphology and biochemistry after cardiac transplantation. Am J Cardiol 1997; 79: 630–4PubMedGoogle Scholar
  80. 80.
    Stratton JR, Graham JK, Daly RC, et al. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure. Circulation 1994; 89: 1624–31PubMedGoogle Scholar
  81. 81.
    Lampert E, Mettauer B, Hoppeler H, et al. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol 1996; 28: 980–4PubMedGoogle Scholar
  82. 82.
    Braith RW, Limacher MC, Leggett SH, et al. Skeletal muscle strength in heart transplant recipients. J Heart Lung Transplant 1993; 12: 1018–23PubMedGoogle Scholar
  83. 83.
    Braith RW. Exercise training in patients with CHF and heart transplant recipients. Med Sci Sports Exerc 1998; 30: S367-78PubMedGoogle Scholar
  84. 84.
    Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210–4PubMedGoogle Scholar
  85. 85.
    Andreassen AK, Kvernebo K, Jorgensen B, et al. Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation. Am Heart J 1998; 136: 320–8PubMedGoogle Scholar
  86. 86.
    Andreassen AK, Gullestad L, Holm T, et al. Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients. Clin Transpl 1998; 12: 324–32Google Scholar
  87. 87.
    Hambrecht R, Fiehn E, Weigle C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709–15PubMedGoogle Scholar
  88. 88.
    Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39: 287–324PubMedGoogle Scholar
  89. 89.
    Sinoway L, Shenberger J, Wilson J, et al. A 30-day forearm work protocol increases maximal forearm blood flow. J Appl Physiol 1987; 62: 1063–7PubMedGoogle Scholar
  90. 90.
    Muchmore JS, Cooper DK, Ye Y, et al. Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991; 23: 1184–5PubMedGoogle Scholar
  91. 91.
    Rivas M, Kim TS, Sharon RS, et al. Bone loss and fractures occur within 6 months of heart transplantation [abstract]. J Bone Miner Res 1992; 7: 352AGoogle Scholar
  92. 92.
    Berguer DG, Krieg MA, Thiebaud D, et al. Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc 1994; 26: 2649–51PubMedGoogle Scholar
  93. 93.
    Braith RW, Mills RM, Welsch MA, et al. Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol 1996; 28: 1471–7PubMedGoogle Scholar
  94. 94.
    Shane E, Rivas MCD, Silverberg SJ, et al. Osteoporosis after cardiac transplantation. Am J Med 1993; 94: 257–64PubMedGoogle Scholar
  95. 95.
    Muchmore JS, Cooper KC, Ye Y, et al. Prevention of loss of vertebral bone density in heart transplant patients. J Heart Lung Transplant 1992; 11: 959–64PubMedGoogle Scholar
  96. 96.
    Lukert B. Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego (CA): Academic Press, 1996: 801–20Google Scholar
  97. 97.
    Rich GM, Mudge GH, Laffel GL, et al. Cyclosporine A and prednisone associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11: 950–8PubMedGoogle Scholar
  98. 98.
    Van Cleemput J, Daenen W, Geusens P, et al. Prevention of bone loss in cardiac transplant recipients. Transplantation 1996; 61: 1495–9PubMedGoogle Scholar
  99. 99.
    Perkoff GT, Silber R, Tyler FH, et al. Studies in disorders of muscle: XII. Myopathy due to the administration of therapeutic amounts of 17-hydroxycorticosteroids. Am J Med 1959; 26: 891Google Scholar
  100. 100.
    Horber FF, Hoppeler H, Herren D, et al. Altered ultrastructure and mixed fiber type atrophy of skeletal muscle in renal transplant patients treated with prednisone. Kidney Int 1986; 30: 411–6PubMedGoogle Scholar
  101. 101.
    Horber FF, Hoppeler H, Scheidegger JR, et al. Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids. J Clin Invest 1987; 79: 1181–90PubMedGoogle Scholar
  102. 102.
    O’Connell JB. Medical complications in patients after cardiac transplantation. In: Hosenpud J, Conanoglu D, Norman D, et al., editors. Cardiac transplantation. New York (NY): Springer-Verlag, 1991: 191–211Google Scholar
  103. 103.
    Almon RR, Dubois DC. Fiber-type discrimination in disuse and glucocorticoid-induced atrophy. Med Sci Sports Exerc 1990; 22: 304–11PubMedGoogle Scholar
  104. 104.
    Dubois DC, Almon RR. Glucocorticoid sites in skeletal muscle: adrenalectomy maturation, fiber type, and sex. Am J Physiol 1984; 247: E118–25PubMedGoogle Scholar
  105. 105.
    Muller R, Kugelberg E. Myopathy in Cushing’s syndrome. J Neurol Neurosurg Psychiatry 1959; 22: 314PubMedGoogle Scholar
  106. 106.
    Ehrman J, Keteyian S, Fedel F, et al. Ventilatory threshold after exercise training in orthotopic heart transplant recipients. J Cardiopulm Rehabil 1992; 12: 126–30Google Scholar
  107. 107.
    Saini J, Geny B, Brandenberger G, et al. Training effects on the hydromineral endocrine responses of cardiac transplant patients. Eur J Appl Physiol 1995; 70: 226–33Google Scholar
  108. 108.
    Lampert E, Oyono-Engguelle S, Mettauer B, et al. Short endurance training improves lactate removal ability in patients with heart transplants. Med Sci Sports Exerc 1996; 28: 801–7PubMedGoogle Scholar
  109. 109.
    Charloux A, Brandenberger G, Lampert E, et al. Moderate endurance training has no effect on the parathyroid function of heart transplant patients. Eur J Appl Physiol 1997; 76: 134–9Google Scholar
  110. 110.
    Lampert E, Mettauer B, Hoppeler H, et al. Skeletal muscle response to short endurance training in heart transplant recipients. J Am Cardiol 1998; 32: 420–6Google Scholar
  111. 111.
    Zhao QM, Mettauer B, Epailly E, et al. Effect of exercise training on leukocyte subpopulations and clinical course in cardiac transplant patients. Transplant Proc 1998; 30: 172–5PubMedGoogle Scholar
  112. 112.
    Brubaker P, Berry MJ, Brozena SC, et al. Relationship of lactate and ventilatory thresholds in cardiac transplant patients. Med Sci Sports Exerc 1993; 25: 191–6PubMedGoogle Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  1. 1.Center For Exercise Science, College of Health and Human Performance, and College of Medicine (Division of Cardiology)University of FloridaGainesvilleUSA

Personalised recommendations